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Present study investigates the beneﬁcial role of the aqueous extract of the fruits of Pithecellobium dulce (AEPD) against carbon
tetrachloride (CCl4)-induced hepatic injury using a murine model. AEPD has been found to possess free radical (DPPH, hydroxyl
and superoxide) scavenging activity in cell-free system. CCl4 exposure increased the activities of various serum maker enzymes
and intracellular reactive oxygen species (ROS) production. In line with these ﬁndings, we also observed that CCl4 intoxication
increased the lipid peroxidation and protein carbonylation accompanied by decreased intracellular antioxidant defense, activity
of cytochrome P450 and CYP2E1 expression. DNA fragmentation and ﬂow cytometric analyses revealed that CCl4 exposure
caused hepatic cell death mainly via the necrotic pathway. Treatment with AEPD both pre- and post-toxin exposure protected
the organ from CCl4-induced hepatic damage. Histological ﬁndings also support our results. A well-known antioxidant vitamin C
was included in this study to compare the antioxidant potency of AEPD. Combining all, results suggest that AEPD protects murine
liver against CCl4-induced oxidative impairments probably via its antioxidative property.
1.Introduction
Liver diseases are a major problem throughout the world.
Hepatic injury, induced by haloalkanes, has been recognized
as one of the most common toxicological problems [1].
Carbon tetrachloride (CCl4), one of the chlorinated hydro-
carbons, is widely used in various industries as a solvent.
It is also used in medicine as a vermifuge in the treatment
of hookworm disease. Exposure to CCl4 by inhalation,
ingestion or absorption through the skin resulted in many
cases of poisoning. In addition, CCl4 is used as a model
for studying free-radical-induced liver injury and screening
hepato-protective drugs [2]. Prolonged administration of
CCl4 causes ﬁbrosis, cirrhosis and hepatic carcinoma [3].
Emerging evidences indicate that oxidative stress might
be a pivotal originating factor in the pathogenesis of
CCl4-induced liver diseases [4, 5]. Although some of the
basic mechanisms of free-radical reactions following CCl4
administration are largelyknown, a potential therapy against
hepatotoxicity has not yet been achieved.
Numerous medicinal plants and their formulations are
used for liver disorders in ethno-medical practice as well as
traditional system of medicine in India [6, 7]. Plant products
play a beneﬁcial role in the management of various liver
disorders [8–13]. In the absence of a reliable liver protective
drug in the modern medicine, a number of medicinal
preparationsinayurvedaarerecommendedforthetreatment
ofliverdisorders.Pithecellobiumdulceisawell-knownIndian
medicinal plant. Pithecellobium dulce has been commonly
used for fencing and tanning, as fodder for feed and pods
for food. Infusions of diﬀerent parts of P. dulce have been
traditionally used to treat diseases, for example, skin of the
stem is used for dysentery, leaves for intestinal disorders and
seeds for ulcers [14, 15].
Present study has been carried out to investigate the
protective role of the aqueous extract of the fruits of P. dulce
(AEPD) against CCl4-induced hepatic disorders. First, the
radical scavenging activity of the extract was determined
from its DPPH (1,1-diphenyl-2-picrylhydrazyl) radical
quenching ability and the data were compared to those2 Evidence-Based Complementary and Alternative Medicine
obtained from a known free-radical scavenger, vitamin
C. Secondly, dose- and time-dependent studies have been
conducted to evaluate the optimum conditions necessary for
the extract to exhibit its maximum protective activity against
CCl4-induced hepatic oxidative damages by measuring the
levels of the serum marker enzymes, alanine transaminase
(ALT) and alkaline phosphatase (ALP). The extent of hepatic
damages caused by CCl4 and the protective role of AEPD
was evaluated by measuring the (i) activities of intracellular
antioxidant enzymes; (ii) the levels of cellular metabolites;
(iii) the levels of lipid peroxidation, protein carbonylation
(PC), intracellular reactive oxygen species (ROS) production
and (iv) the activity of cytochrome P450 and the expression
of its isoenzyme (CYP2E1). The mode of hepatic cell death
has been evaluated by ﬂow cytometry and DNA fragmenta-
tion analysis. In addition, histological studies were carried
out to assess the ultrastructural changes in murine livers.
2. Methods
2.1.Plant. Pithecellobiumdulce,oneoftheimportantmedic-
inal plants of India, belongs to the family of Fabaceae. For
this particular study, the fruits were collected in the summer
season of the current year from the local market of Kolkata,
India. After collection, one voucher specimen of this plant
was deposited in the Central National Herbarium (CNH),
Botanical Survey of India (BSI), Howrah, West Bengal,
India.
2.2. Animals. All experiments were performed on Swiss
albino mice (male, body weight 20±2g, purchased from
M/S Gosh Enterprises, Kolkata, India.). The animals were
acclimatizedunderlaboratoryconditionsfor2weekspriorto
the experiments. They were maintained under standard con-
ditions of temperature (23±2◦C) and humidity (50±10%)
with alternating 12h light/dark cycles. The animals had free
access to tap water and were fed standard pellet diet (Agro
Corporation Private Ltd., Bangalore, India). The ethical
committee of Bose Institute approved the guidelines of the
experimental procedure using the animals (mice) and all
the experiments with animals were carried out according to
guidelines of the institutional animal ethical committee.
2.3.ChemicalsandOtherReagents. Bradfordreagent,DPPH,
bovine serum albumin (BSA) and protein estimation kit
were purchased from Sigma-Aldrich Chemical Company,
(St. Louis, MO, USA). CCl4, disodium hydrogen phosphate
(Na2HPO4), 1-chloro-2,4-dinitrobenzene (CDNB), 5,5 -
dithiobis(2-nitrobenzoic acid) [DTNB, (Ellman’s reagent)],
ethylene diamine tetra acetic acid (EDTA), glacial acetic
acid, hydrogen peroxide (H2O2), nicotinamide adenine
dinucleotide reduced (NADH), sodium dihydrogen phos-
phate (NaH2PO4), nitro blue tetrazolium (NBT), phenazine
methosulphate (PMT), reduced glutathione (GSH), so-
dium pyrophosphate, potassium dihydrogen phosphate
(KH2PO4), trichloroacetic acid (TCA), thiobarbituric acid
(TBA) were bought from Sisco Research Laboratory, India.
2.4. Aqueous Fruit Extract Preparation. After collection, the
fruits were cut into small pieces and homogenized in
50mM phosphate buﬀer, pH 7.2 at 4◦C. The homogenized
mixture was centrifuged at 12000g for 30min to get rid of
unwanted debris and lyophilized. The freeze-dried material
was weighed, dissolved in the same phosphate buﬀer and
used in diﬀerent experiments needed for this study.
2.5. Qualitative Analysis of AEPD. Phytochemical analysis of
AEPD was carried out to investigate the presence of active
ingredientslikeﬂavonoids,saponins,phenolics,steroids,and
so forth.
A portion of crude powder was heated with 10ml of
ethyl acetate over a steam bath for 3min. The mixture was
ﬁltered and 4ml of the ﬁltrate was shaken with 1ml of
dilute ammonia solution. Appearance of yellow coloration
conﬁrmed the presence ﬂavonoids in the extract [16].
To ﬁnd out the presence of saponins, small amount
(0.5g) of crude powder was shaken with water in a test tube
anditwaswarmedinawaterbath.Persistentfrothformation
indicated the presence of saponins in the extract [17, 18].
A b o u t0 . 5 go fc r u d ep o w d e rw a sh e a t e dw i t h5 m l
of ethyl alcohol over a steam bath for 3min and then
few drops of neutral ferric chloride solution were added.
Appearance of violet coloration conﬁrmed the presence
phenolic compounds in the extract [19].
For the analysis steroid compounds, about 0.5g of crude
powder was dissolved in 5ml of methanol. 1ml of the
alcoholic extract was treated with 0.5ml of acetic anhydride
and the solution was cooled in ice. The mixture was then
mixed with 0.5ml of chloroform and 1ml of concentrated
sulfuric acid [20]. A reddish-brown ring was formed at the
separations level of the two liquids and appearance of this
ring indicated of the presence of steroids in the extract.
2.6. Quantitative Analysis of AEPD
2.6.1. Flavonoid Content Estimation. Ten grams of crude
powderwasextractedrepeatedlywith100mlof80%aqueous
methanol at room temperature. The whole solution was
ﬁltered through Whatman ﬁlter paper no. 42 (125m). The
ﬁltrate was transferred into a crucible, evaporated into
dryness and weighed to a constant weight [21].
2.6.2. Determination of Saponin Content. Twenty grams of
crude powder was put into a conical ﬂask and 100ml of
20% aqueous ethanol were added. The samples were heated
over a hot water bath for 4h with continuous stirring at
about 55◦C. The mixture was ﬁltered and the residue was
extracted with another 200ml of 20% ethanol. The extract
was reduced to 40ml over water bath at about 90◦C. The
concentrate was transferred into 250ml separating funnel,
20ml of diethyl ether was added and the mixture was shaken
vigorously. The aqueous layer was recovered while the ether
layer was discarded. The puriﬁcation process was repeated.
An amount of 60ml of n-butanol was then added. The
combined n-butanol extracts were washed twice with 10ml
of 5% aqueous sodium chloride. The remaining solution was
heated in a water bath. After evaporation, the samples wereEvidence-Based Complementary and Alternative Medicine 3
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Figure 1: Schematic diagram of in vivo experimental protocol. CCl4 was administered orally at a dose of 1mlkg−1 body weight in liquid
paraﬃn (1:1, v/v). AEPD and vitamin C were administered at a dose of 200and 100mgkg−1 body weight, respectively. The animals were
sacriﬁced under light ether anesthesia at the speciﬁed time as mentioned in the ﬁgure.
dried in the oven to constant weight and the saponin content
was calculated [22].
2.6.3. Total Phenolic Compounds Estimation. The content of
total phenolic compounds of the extract was determined
according to McDonald’s method using Folin–Ciocalteau
reagent (Gallic acid as a standard) [23].
2.6.4. Dose- and Time-Dependent Eﬀect of AEPD. To ﬁnd
out the dose of AEPD necessary for optimum protection
against CCl4-induced hepato-toxicity mice were divided into
10 groups each consisting of six animals in each. First two
groups were served as normal control (received only water
as vehicle) and toxin control (received CCl4 at a dose of
1mlkg −1 body weight for 2 days, orally), respectively. Other
eight groups of animals were treated with AEPD orally at
a dose of 25, 50, 75, 100, 150, 200, 250 and 300mgkg−1
body weight for 7 days prior to CCl4 treatment (at a dose
of 1mlkg−1 body weight for 2 days, orally) respectively.
Todetermine thetime dependenteﬀectsofAEPDagainst
CCl4-intoxicated hepatic disorders, mice were divided into
nine groups each consisting of six animals. First two groups
wereservedasnormalcontrol(receivedonlywaterasvehicle)
and toxin control (received CCl4 a tad o s eo f1m lk g −1 body
weight for 2 days, orally) respectively. Other seven groups
of animals were treated with AEPD orally at a dose of
200mgkg−1 body weight, once daily for 1, 3, 5, 7, 10, 12
and 14 days prior to CCl4 intoxication (at a dose of 1mlkg−1
body weight for 2 days, orally).
A l lm i c ew e r es a c r i ﬁ c e d2 4ha f t e rt h eﬁ n a ld o s eo fC C l 4
administration. The ALT levels were measured from the
blood serum of all the experimental mice.
2.7. Experimental Animals Grouping and Treatment. Figure 1
represents the animals grouping and their treatment proce-
dure.
2.8. Liver Weight to Body Weight Ratio Determination. After
scariﬁcation, the livers from experimental animals were
quicklyexcisedandweighed.Theratioofliverweighttobody
weight was then measured for each.
2.9. Serum Marker Enzymes Inhibition Eﬃciency. For the
assessment of serum-speciﬁc markers (ALT and ALP) related
to hepatic dysfunction, blood samples were collected by
puncturing mice hearts of all experimental animals, kept
overnight for clotting and then centrifuged at 3000g for
10min. ALT and ALP levels (in the sera) were measured by
using the kits from Span Diagnostic limited, India.
2.10. Liver Tissue Homogenate Preparation. About 200mg
liver tissue was homogenized using glass homogenizer in
100mM phosphate buﬀer (pH 7.4), containing 1mM EDTA,
PMSF (proteinase inhibitor, 1mM) as well as phosphatase
inhibitor cocktail (1:100 dilution) and the mixture was
centrifugation at 12000g for 30min at 4◦C. The supernatant
was collected and used for the experiments.
2.11. Tissue Homogenate Protein Content Determination.
The protein contents of the liver tissue homogenates were4 Evidence-Based Complementary and Alternative Medicine
measured by the method of Bradford using crystalline BSA
as standard [24].
2.12. Lipid Peroxidation, Lipid Hydroperoxide and PC Inhibi-
tion Eﬃciency. The level of lipid peroxidation was measured
in terms of the formation of thiobarbituric acid reactive
substances (TBARS) according to the method of Esterbauer
and Cheeseman [25]. Liver tissue homogenate, containing
1mg protein, were mixed with 1ml TCA (20%), 2ml TBA
(0.67%) and heated for 1h at 100◦C. During heating step
0.01% butylated hydroxyl toluene was added to abolish
the metal catalyzes auto-oxidation of lipids. After cooling,
the precipitate was removed by centrifugation. The pink
pigment from all the samples was separately extracted
with 4ml of n-butanol. The absorbance of the sample was
measured at 535nm using a blank containing all the reagents
except the sample. As 99% TBARS are malondialdehyde
(MDA), so TBARS concentrations of the samples were
calculated using the extinction co-eﬃcient of MDA, which
is 1.56×105 M−1cm−1 [25].
The concentration of lipid hydroperoxide (LHP) in the
experimental sample was estimated by the FOX reagent
as described by Jiang et al. [26]. For this purpose, the
tissue homogenate was mixed with FOX reagent [88mg of
butylated hydroxy toluene, 7.6mg xylenol orange and 9.8mg
of ammonium iron (II) sulfate in 90ml methanol and 10ml
of H2SO4]. After 30min the absorbance of the solution was
read at 560nm. The amount of hydroperoxide produced
was calculated using the molar extinction coeﬃcient of
4.6×104 M−1cm−1.
Protein carbonyl contents in the liver tissue samples
were determined according to the method of Uchida and
Stadtman [27] .T h et i s s u eh o m o g e n a t ew a sm i x e dw i t ha n
equal volume of 0.1% (w/v) 2,4-DNPH in 2N HCl and
incubated for 1h at room temperature and then treated
with 20% TCA. After centrifugation, the precipitate was
extractedthreetimeswithethanol/ethylacetateanddissolved
in 8M guanidine hydrochloride in 133mM Tris buﬀer
containing 13mM EDTA. The absorbance was recorded at
365nm. The results were expressed as nanomoles of DNPH
incorporated/mg protein based on the molar extinction
coeﬃcient of 22000M−1cm−1 for aliphatic hydrazones.
2.13. Antioxidant Enzymes and Metabolites Assay
2.13.1. SOD. In case of SOD assay tissue homogenates were
centrifuged at 600g for 8min at 4◦C. Supernatants were
decanted and re-centrifuged at 5500g for 15min to form
mitochondrialpellets.Thesupernatantwaskeptas“cytosolic
fraction”. The pellets were resuspended in MSH buﬀer
(210mM mannitol, 70mM sucrose, 5mM Hepes, pH 7.5)
without EDTA and termed as “mitochondrial fraction”. The
activities of Mn–SOD were measured in the mitochondrial
and Cu/Zn–SOD in the cytosolic fractions following the
method of Nishikimi et al. [28] and Kakkar et al. [29]. The
addition of cyanide ion (in mitochondrial fraction) to a
ﬁnal concentration of 2mM inhibits Cu/Zn–SOD activity
by over 90%. Mn–SOD is unaﬀected by cyanide. For both
measurements, about 5μg of protein was mixed with sodium
pyrophosphate buﬀer, PMT and NBT. The reaction was
started by the addition of NADH. The reaction mixture
was then incubated at 30◦C for 90s and stopped by the
addition of 1ml of glacial acetic acid. The absorbance of the
chromogen formed was measured at 560nm. One unit of
SODactivityisdeﬁnedastheenzymeconcentrationrequired
to inhibit chromogen production by 50% in 1min under the
assay condition.
2.13.2. CAT. T h ee n z y m eC A Tc o n v e r t sH 2O2 formed via
the action of SOD on superoxide radical into water. The
CAT activity was measured by the method of Bonaventura
et al. [30]. About 5μg protein from spleen homogenate was
mixed with 2.1ml of 7.5mM H2O2 and a time scan was
performed at 240nm spectrophotometrically for 10min at
25◦C. The disappearance of peroxide depending on the CAT
activity was observed. One unit of CAT activity is deﬁned as
the amount of enzyme, which reduces 1μmol of H2O2 per
minute.
2.13.3. GST. The activity of GST was measured by the
method of Habig et al. [31]. The reaction mixture con-
tained suitable amount of enzyme (25μg of protein in
homogenates), potassium phosphate buﬀer, EDTA, CDNB
and GSH. The reaction was carried out at 37◦C and moni-
tored spectrophotometrically by the increase in absorbance
of the conjugate of GSH and CDNB at 340nm. A blank was
run in absence of the enzyme. One unit of GST activity is
deﬁned as the 1μmol of product formation per minute.
2.13.4. GR. GR activity was determined according to the
method of Smith et al. [32]. The increase in absorbance at
412nm was monitored spectrophotometrically for 3min at
24◦C.Theenzymeactivitywascalculatedusingmolarextinc-
tion coeﬃcient of 13600M−1cm−1. One unit of enzyme
activity is deﬁned as the amount of enzyme, which catalyzes
the oxidation of 1μmol NADPH per minute.
2.13.5. GPx. GPx activity was assayed according to the
method of Flohe and Gunzler [33]. About 50μlo fs a m p l e
was mixed with 550μlo f0 . 1MK H 2PO4 buﬀer containing
1mM EDTA (pH 7.5), 50μlo f2 m MN a N 3, 100μlo fG R
(2.4Uml−1)and100μlof10mMGSH.After10minofincu-
bationat37◦C,100μlof1.5mMNADPHinwaterwasadded
to the above mixture. The reaction was started by adding
100μlo fp r e - w a r m e d( 3 7 ◦C) 1.5mM H2O2 and the decrease
in absorbance at 340nm were monitored spectrophotomet-
rically for 5min. The enzyme activity was calculated using
molar extinction coeﬃcient of 6.22×103 M −1cm−1.O n e
unit of enzyme activity is deﬁned as the amount of enzyme
that catalyzes the oxidation of 1μmol NADPH per minute.
2.13.6. GSH. GSH level was measured by the method of
Ellman [34] .L i v e rt i s s u eh o m o g e n a t e( 7 2 0μl) was diluted to
1440μl by using Tris-EDTA buﬀer and 5% TCA was added
to it to precipitate the protein content of the homogenate.
After centrifugation (10000g for 5min) the supernatant was
taken, DTNB solution (Ellman’s reagent) was added to it and
the absorbance was measured at 417nm. A standard graphEvidence-Based Complementary and Alternative Medicine 5
was drawn using diﬀerent concentrations of GSH solution
(1mgml−1) and ﬁxed concentration of DTNB. With the
help of this graph GSH content of tissue homogenates were
calculated. The method describes here basically determines
the total non-protein sulfhydryls (NPSH) in the experimen-
tal samples as proteins are precipitated initially by TCA.
However, GSH is the most abundant NPSH in the tissue.
Thus, the aforementioned method can be regarded as the
GSH estimation procedure.
2.13.7. GSSG. Glutathione disulﬁde (GSSG) was assessed
by measuring its level using a kit from Calbiochem, USA
following the method of Finck et al. [35]. In this method,
GSSG was enzymatically reduced to GSH (in presence of
NADPH and GR as given below) which reacts with DTNB
to produce the yellow colored TNB
GSSG+NADPH+H+ GR
− − → 2GSH+NADP
GSH+DTNB −→ TNB (Yellow color)
Brieﬂy, tissue samples were homogenized in ice cold m-
phosphoric acid (100gl−1, Fluka). This treatment resulted in
the precipitation of the proteins. After allowing the mixture
to stand for 5min at room temperature, homogenates
were centrifuged (10000g; 10min at 4◦C). Supernatants
were frozen at –80◦C until further analysis. Prior to the
estimation of GSSG, neutralization was achieved by adding
5μl of triethanolamine (4mmoll−1, Sigma Chemicals) to
a 100μl supernatant. For GSSG assay, the thiol scaveng-
ing reagent 1-methyl-2-vinylpyridinium triﬂuoromethane-
sulfonate (M2VP) was used to mask GSH very rapidly.
An amount of 10μl of M2VP was added to 100μlo f
neutralizedsupernatant.Then100μloftherecyclingreagent,
which contained NADPH (0.30mM), DTNB (0.225mM)
and GR (1.6Uml−1) in a 100mM phosphate/1mM EDTA
buﬀer (pH 7.4), was added. The change of absorbance was
monitored at 412nm for 3min with a spectrophotometer.
Standards and test samples were run in triplicate for each
assay and the measurements were repeated three times. The
reaction rate and calibration curves were used to calculate
concentrations of GSSG.
2.14. Total Thiols. Total thiols (total protein bound as
well as non-protein bound sulfhydryl groups) content was
measured according to the method of Sedlak and Lindsay
[36] with some modiﬁcations. About 50μl of the tissue
homogenate was mixed with 0.6ml of Tris-EDTA buﬀer
and 40μlo f1 0m MD T N Bi nm e t h a n o l .T h eﬁ n a lv o l u m e
was made up to 1ml by adding methanol. The reaction
mixture was incubated at room temperature for 20min and
the absorbance wasmeasuredat412nm. The contentof total
thiols was calculated using molar extinction coeﬃcient of
13600M−1 cm−1.
2.15. Intracellular ROS Production Inhibition. Intracellular
ROS production was estimated by using 2,7-dichloroﬂu-
oresceindiacetate(DCFDA)asaprobefollowingthemethod
of LeBel and Bondy [37] as modiﬁed by Kim et al. [38].
DCFDAdiﬀuses through the cell membrane where it is enzy-
matically deacetylated by intracellular esterases to the more
hydrophilic nonﬂuorescent reduced dye dichloroﬂuorescin.
In the presence of reactive oxygen metabolites, nonﬂuores-
cent DCFH rapidly oxidized to highly ﬂuorescent product
DCF. For in vivo study, 100μlo ft i s s u eh o m o g e n a t e sw e r e
incubated with the assay media (20mM Tris–HCl, 130mM
KCl, 5mM MgCl2,2 0 m MN a H 2PO4, 30mM glucose and
5μMD C F D A )a t3 7 ◦C for 15min. The formation of DCF
was measured at the excitation wavelength of 488nm and
emission wavelength of 610nm for 10min by using ﬂuo-
rescence spectrophotometer (HITACHI, Model No. F4500)
equipped with a FITC ﬁlter. Representative images of the
ﬂuorescent cell were taken under ﬂuroscence microscope.
2.16. Cytochrome P450 Activity Study. The reaction mixture
contained 100μg liver microsomal protein in a 100-μl
reaction system containing 0.4mM p-nitrophenol and 1mM
NADPH. The reaction was incubated at 37◦C and stopped
after 60min by addition of 30ml 20% TCA and placed
on ice. Brieﬂy after centrifugation, the sup was taken and
mixed with 2M NaOH and the absorbance measured at
546nm. 4-Nitrocatechol formation was quantitated by using
an extinction coeﬃcient of 10.28mM−1 cm−1 [39].
2.17. Immunoblotting. Samples containing 50μg proteins
were subjected to 10% SDS–PAGE and transferred to
a nitrocellulose membrane. Membranes were blocked at
room temperature for 2h in blocking buﬀer containing
5% non-fat dry milk to prevent non-speciﬁc binding and
then incubated with primary antibody, CYP2E1 (1:1000
dilution), overnight at 4◦C .T h em e m b r a n ew a sw a s h e di n
TBST (50mmoll−1 Tris–HCl, pH 7.6, 150mmoll−1 NaCl,
0.1% Tween 20) for 30min and incubated with appropriate
HRP conjugated secondary antibody (1:2000 dilution)
for 2h at room temperature and developed by the HRP
substrate 3,3 -diaminobenzidine tetrahydrochloride (DAB)
system (Bangalore, India).
2.18. DNA Damage Inhibition Analysis. The extent of DNA
fragmentation (DNA ladder) has been assayed by elec-
trophoresing genomic DNA samples, isolated from normal
as well as experimental mouse liver, on agarose/ethydium
bromide gel by the procedure described by Sellins and
Cohen [40].
2.19. Detection of Cell Death Pathway by Flow Cytometry.
The ﬂow cytometric analysis was done on BD-LSR ﬂow
cytometer. Cell debris, characterized by a low FSC/SSC was
excluded from analysis. The data was analyzed by Cell Quest
software.
The apoptotic andnecrotic celldistribution wasanalyzed
by Annexin V binding and PI uptake. Positioning of quad-
rants on Annexin V/PI dot plots was performed and living
cells (Annexin V−/PI−), early apoptotic/primary apoptotic
cells (Annexin V+/PI−), late apoptotic/secondary apoptotic
cells (Annexin V+/PI+) and necrotic cells (Annexin V−/PI+)
weredistinguished.Therefore,thetotalapoptoticproportion
included the percentage of cells with ﬂuorescence Annexin6 Evidence-Based Complementary and Alternative Medicine
V+/PI− and Annexin V+/PI+. The cells were suspended in
1ml binding buﬀer (1x). An aliquot of 100μl was incubated
with 5μlA n n e x i nV - F I T Ca n d1 0lP If o r1 5m i ni nd a r ka t
room temperature and 400μl binding buﬀer (1x) was added
toeachsample.TheFITCandPIﬂuorescenceweremeasured
through FL-1 ﬁlter (530nm) and FL-2 ﬁlter (585nm),
respectively, and 10000 events were acquired.
2.20. Histological Studies. Livers from the normal and exper-
imental mice were ﬁxed in 10% buﬀered formalin and
were processed for paraﬃn sectioning. Sections of about
5μm thickness were stained with hematoxylin and eosin to
evaluate under light microscope.
2.21. Free-Radical Scavenging Activity in Cell-Free System
2.21.1. DPPH. The antioxidant activity of the aqueous
extract was measured using the DPPH radical [41]. DPPH
solutions (2ml) in methanol (125μM) and 2ml of tested
samples with diﬀerent concentrations were mixed in the
tubes. The solution was shaken and incubated at 37◦C
for 30min in dark. The decrease in absorbance at 517nm
was measured against methanol blank using a UV/Visible
spectrophotometer. Percent inhibition was calculated by
comparing the absorbance values of control and the sample.
Percentage inhibition= ((A1 − A2)/A2) × 100, where A1 is
the absorbance of the blank and A2 is the absorbance in the
presence of the P. Dulce extract. A parallel experiment was
carried out under the same conditions in which P. Dulce
extract was replaced by vitamin C and used as a positive
control.
2.21.2. Hydroxyl. The hydroxyl radical scavenging activity
of the extract has been investigated following the method
of Nash [42]. In vitro hydroxyl radicals were generated by
Fe3+/ascorbic acid system. The detection of hydroxyl radicals
was carried out by measuring the amount of formaldehyde
produced from the oxidation of dimethyl sulfoxide (DMSO).
The formaldehyde produced was detected spectrophotomet-
rically at 412nm.
2.21.3. Superoxide. The superoxide radical scavenging activ-
ity was measured following the method of Siddhuraju and
Becker [43]. The reaction mixture contained 0.1M phos-
phate buﬀer, pH 7.4, 150μM nitroblue tetrazolium (NBT),
60μM phenazine methosulphate (PMT), 468μM NADH
and diﬀerent concentrations of the AEPD. The mixture was
incubated in the dark for 10min at 25◦C and the absorbance
was read at 560nm. Results were expressed as percentage
inhibition of the superoxide radicals.
2.22. Statistical Analysis. All the values are expressed as
mean±SD (n=6). Signiﬁcant diﬀerences between the
groups were determined with SPSS 10.0 software (SPSS Inc.,
Chicago, IL, USA) for Windows using one-way analysis of
variance (ANOVA) and the group means were compared
by Student-Newman-Keuls post hoc tests. A diﬀerence was
considered signiﬁcant at the P<.05 level.
Table 1: Qualitative analysis of the AEPD.
Serial No. Component Abundance
1 Flavonoids +
2 Saponins +
3 Phenolics +
4 Steroids +
“+” sign indicates the presence of the compounds in the AEPD.
Table 2: Quantitative analysis of the AEPD.
Serial No. Component Concentration
1 Flavonoid content 55.47±1.57
(mgg−1 dry weight material)
2 Saponin content 72.81±2.35
(mgg−1 dry weight material)
3 Phenol content 3.12±0.08
(mgml−1)
3. Results
3.1. Phytochemical Screening of AEPD for Active Components.
The present study investigated the presence of medicinally
active constituents in the fruit extract. Qualitative analysis
(Table 1) revealed that ﬂavonoids, saponins, phenolics and
steroids were present in the fruit extract of the plant.
Quantitative estimation of the chemical constituents in the
studied medicinal plant is summarized in Table 2.
3.2. Dose- and Time-Dependent Protective Action of AEPD
against CCl4 Intoxication. In the present study, we used ALT
assay to determine the optimum dose and time necessary for
AEPD to protect mouse liver against CCl4-induced hepatic
oxidative damages. The experimental results of this study
havebeenrepresentedinFigures2and3,respectively.Results
show that CCl4 intoxication signiﬁcantly increased the ALT
activity in serum. AEPD administration decreased the ALT
activity linearly up to a dose of 200mgkg−1 body weight,
when applied for 5 days prior to CCl4 intoxication. This dose
of AEPD and time of treatment were used for the subsequent
experiments.
3.3. Liver Weight to Body Weight Ratio. CCl4 intoxication
usually reduces the weight of diﬀerent organs in pathophys-
iological situations. We, therefore, checked whether the liver
weight of the experimental animals was aﬀected by CCl4
exposure and if that happened whether AEPD could protect
it. Table 3 shows that CCl4 toxicity lowers liver weight to
body weight ratio (∼30%) and that could be prevented by
the treatment with AEPD prior to toxin exposure. Post-
treatment with AEPD also showed similar result as the pre-
treated groups. It is evident from the data that CCl4-induced
hepatic pathophysiology could be protected by AEPD.
3.4. Serum-Speciﬁc Markers Related to Hepatic Dysfunction.
Table 3 represents the status of the serum speciﬁc marker
enzymes related to liver dysfunction. CCl4 administrationEvidence-Based Complementary and Alternative Medicine 7
Table 3: Ratio of the liver weight to the body weight and the activities of the serum marker enzymes related to hepatic dysfunction.
Animal
groups
Ratio of the liver
weight to the body
weight (%)
Activities of the serum marker enzymes
ALT ALP
Vehicle 4.78±0.26(a) 46.22±2.42(a) 25.88±1.32(a)
AEPD 4.72±0.25(a) 49.15±2.47(a) 28.95±1.28(a)
CCl4 3.33±0.18(b) 97.39±4.88(b) 75.77±3.82(b)
AEPD + CCl4 4.45±0.24(a) 54.58±2.75(a) 52.98±2.66(c)
CCl4 + AEPD 4.29±0.26(a) 62.37±3.12(a) 55.29±2.77(c)
VitC + CCl4 4.55±0.29(a) 50.49±2.55(a) 44.15±2.22(c)
Recovery 3.65±0.17(b) 87.31±4.39(b) 70.56±3.55(b)
ALT: IUl−1 and ALP: KA. Data are mean±SD, for six animals per group and were analyzed by one-way ANOVA, with Student-Newman-Keuls post hoc tests.
Diﬀerences were attributed at P<.05, and homogeneous subgroups share common superscripted letters.
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Figure 2: Dose dependent eﬀect of AEPD on ALT activity against
CCl4-inducedhepato-toxicity.Vehicle:ALTactivityinnormalmice,
CCl4: ALT activity in CCl4-treated mice, AEPD-25, AEPD-50,
AEPD-75, AEPD-100, AEPD-150, AEPD-200, AEPD-250, AEPD-
300: ALT activity in AEPD-treated mice for 7 days at a dose of 25,
50, 75, 100, 150, 200, 250 and 300mgkg−1 body weight prior to
CCl4 intoxication. Data are mean±SD, for six animals per group
and were analyzed by one-way ANOVA, with Student-Newman-
Keuls post hoc tests. Diﬀerences were attributed at P<.05, and
homogeneous subgroups share common superscripted letters.
caused a signiﬁcant increase in the activities of ALT (∼2-
fold) and ALP (∼3-fold). Pre-treatment with AEPD could
maintain these levels almost close to normal against CCl4-
induced hepatotoxicity. Post treatment with AEPD after
toxin administration also decreased these levels. Results
suggest that AEPD could block the membrane leakage
induced by CCl4-exposure.
3.5. Lipid Peroxidation and PC Inhibition. In oxidative-
stress-related organ pathophysiology, lipid peroxidation and
PC are considered to be the two important parameters. In
the present study, lipid peroxidation has been measured by
estimating the concentration of TBARS and LHP. Table 4
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Figure 3: Time dependent eﬀect of AEPD on ALT activity against
CCl4-inducedhepato-toxicity.Vehicle:ALTactivityinnormalmice,
CCl4: ALT activity in CCl4-treated mice, AEPD-1, AEPD-3, AEPD-
5, AEPD-7, AEPD-10, AEPD-12 and AEPD-14: ALT activity in
AEPD-treated mice at a dose of 200mgkg−1 body weight prior to
CCl4 intoxication for 1, 3, 5, 7, 10, 12 and 14 days respectively.
Data are mean±SD, for six animals per group and were analyzed
by one-way ANOVA, with Student-Newman-Keuls post hoc tests.
Diﬀerences were attributed at P<.05, and homogeneous subgroups
share common superscripted letters.
represents the changes in TBARS, LHP and PC in the
hepatic tissue of the normal and experimental animals.
CCl4 intoxication increased the levels of TBARS (∼2.3-fold)
and LHP (∼2-fold). The level of PC was also signiﬁcantly
elevated(∼2.4-fold)duetoCCl4 toxicity. However, both pre-
and post-treatment with AEPD decreased the levels of lipid
peroxidationaswellasPCsuggestingtheanti-oxidant nature
of AEPD in CCl4-induced hepatic oxidative stress.
3.6. Protective Role Against CCl4-Induced Intracellular ROS
Production. ROS plays a major role in CCl4-induced hepatic
dysfunction and hepatocellular death. In order to asses
the changes in the production of intracellular ROS under8 Evidence-Based Complementary and Alternative Medicine
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Figure 4: The intracellular ROS production was detected by DCF-DA method. (a) Representative images under ﬂuroscence microscope
(original magniﬁcation 400x), (b) intensity of DCF ﬂuorescence (indicator of intracellular ROS level) measured using a ﬂuorescence
spectrophotometer. Vehicle: ROS level in normal animals, AEPD: ROS level in the animals treated with AEPD only; CCl4:R O Sl e v e li n
the CCl4 intoxicated animals; AEPD + CCl4: ROS level in the animals treated with AEPD prior to CCl4 intoxication; CCl4 + AEPD: ROS
levelintheanimalstreatedwithAEPDpost-CCl4 intoxicationandRecovery:ROSlevelintheanimalsofrecoverygroup.Dataaremean±SD,
for six animals per group and were analyzed by one-way ANOVA, with Student-Newman-Keuls post hoc tests. Diﬀerences were attributed at
P<.05, and homogeneous subgroups share common superscripted letters.
Table 4: Levels of the parameters as the index of lipid peroxidation
(TBARS), LHP and PC in the liver tissue of the control and
experimental mice.
Animal groups TBARS LHP PC
Vehicle 7.37±0.39(a) 2.35±0.14(a) 18.91±0.98(a)
AEPD 8.14±0.42(a) 2.41±0.12(a) 18.45±0.95(a)
CCl4 17.25±0.91(b) 4.76±0.25(b) 45.51±2.31(b)
AEPD+CCl4 9.14±0.47(a),(c) 3.55±0.19(c) 20.14±1.03(a)
CCl4 +AEPD 10.37±0.55(c) 3.12±0.17(a) 25.95±1.05(a)
VitC+CCl4 8.75±0.45(a) 2.89±0.15(a) 19.75±0.98(a)
Recovery 15.29±0.77(b) 4.51±0.22(b) 42.25±2.29(b)
TBARS—nmolmg−1 protein; LHP—nmolmg−1 protein and PC—
nmolmg−1 protein. Data are mean±SD, for six animals per group and
were analyzed by one-way ANOVA, with Student-Newman-Keuls post hoc
tests. Diﬀerences were attributed at P<.05, and homogeneous subgroups
share common superscripted letters.
oxidative stress, hepatocytes were isolated from the experi-
mental animals and studied the ROS production assay using
DCFDA under ﬂuorescence microscope and by ﬂuorescence
spectrophotometer also. Figure 4 shows the eﬀect of CCl4
on the intracellular ROS production and its reversal by
the treatment with AEPD. Here, we observed (Figure 4)
that CCl4 administration caused increased production of
intracellular ROS (∼80% as revealed by the increased no
of green ﬂuorescent cells). Treatment with AEPD both
pre- and post-toxin administration decreased (∼40%) the
intracellular ROS level compared to toxin control suggesting
the intracellular ROS scavenging nature of AEPD. Data from
ﬂuorescence spectrophotometric analysis also supported this
result.
3.7. Antioxidant Enzymes Activation. Antioxidant enzymes
are considered to be the ﬁrst line of cellular defense
that prevents cellular ingredients from oxidative damage.
Among them SOD and CAT mutually function as important
enzymesintheeliminationofROS.Inordertoremoveexcess
free radicals from the system, GST and GPx utilize GSH
during their course of reactions. Decrease in GSH content
due to toxicity simultaneously decreased the activities of
GST as well as GPx with a concomitant decrease in the
activity of GSH regenerating enzyme, GR. We, therefore,Evidence-Based Complementary and Alternative Medicine 9
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Figure 5: Eﬀect on the activities of cytochrome P450 in the
hepatic tissue of the experimental animals. Vehicle: activity in
normal animals, AEPD: activity in the animals treated with AEPD
only; CCl4: activity in the CCl4 intoxicated animals; AEPD +
CCl4: activity in the animals treated with AEPD prior to CCl4
intoxication; CCl4 + AEPD: activity in the animals treated with
AEPD post-CCl4 intoxication and Recovery: activity in the animals
of recovery group. Data are mean±SD, for six animals per group
and were analyzed by one-way ANOVA, with Student-Newman-
Keuls post hoc tests. Diﬀerences were attributed at P<.05, and
homogeneous subgroups share common superscripted letters.
determined the activities of these enzymes and presented the
data in Table 5. A signiﬁcant reduction in the activities of all
antioxidant enzymes was observed in the liver tissue of the
CCl4-intoxicated experimental animals. Results suggest that
both pre- as well as post-treatment with AEPD could protect
the ﬁrst line of hepato-cellular defense in oxidative damage
induced by CCl4.
3.8. Cellular Metabolites Alterations. Thiol based antioxidant
system plays second line of cellular defense against reactive
free radicals and other oxidant species mediated oxidative
damage. GSH with its –SH group functions as a catalyst
in disulﬁde exchange reaction. It functions by scavenging
free radicals as well as detoxifying various xenobiotics and
consequently converted to its oxidized form, glutathione
disulﬁde (GSSG). Levels of cellular metabolites like GSH,
GSSG and total thiol have been described in Table 6.T h e
levels of GSH and total thiols were signiﬁcantly decreased
(GSH ∼71%andtotalthiols ∼50%)duetoCCl4 intoxication
along with the increased (∼1.7-fold) level of GSSG. Pretreat-
mentwithAEPDcouldpreventthetoxin-inducedalterations
in the intracellular thiol status. Post treatment with AEPD
also maintained the levels of cellular metabolites close to
normal suggesting the protective nature of AEPD for second
line of hepato-cellular defense against free radicals and other
oxidant species originated due to CCl4 exposure.
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Figure 6: Western blot analysis of the expression of CYP2E1 in
the hepatic tissue of the experimental animals. The relative bands
intensities were determined using NIH image software and the
control band was given an arbitrary value of 1. Vehicle: CYP2E1
expression in normal animals, AEPD: CYP2E1 expression in the
animals treated with AEPD only; CCl4: CYP2E1 expression in the
CCl4 intoxicated animals; AEPD + CCl4: CYP2E1 expression in
the animals treated with AEPD prior to CCl4 intoxication; CCl4
+ AEPD: CYP2E1 expression in the animals treated with AEPD
post-CCl4 intoxication and Recovery: CYP2E1 expression in the
animals of recovery group. Data are mean±SD, for six animals
per group and were analyzed by one-way ANOVA, with Student-
Newman-Keuls post hoc tests. Diﬀerences were attributed at P<.05,
and homogeneous subgroups share common superscripted letters.
A well-known antioxidant, vitamin C, has been included
in the present study as a positive control. Being an
antioxidant, vitamin C could prevent CCl4-induced hepatic
oxidative dysfunction.
3.9. Upregulation of Cytochrome P450 and CYP2E1. The
reactive metabolite trichloromethyl radical (•CCl3)h a s
been formed from the metabolic conversion of CCl4 by
cytochrome P450. As O2 tension rises, a greater fraction
of •CCl3 reacts very rapidly with O2 and more reactive
free radical, CCl3OO• has been generated from •CCl3.
CYP2E1, major isozyme of cytochrome P450 family, is
involved in CCl4 bioactivation and generation of cytotoxic
trichloromethyl radicals, caused hepatotoxicity [44–46].
Alterations in CYP2E1 activity can aﬀect susceptibility to
hepatic injury from CCl4 [46, 47]. Moreover, the reactive
free radicals inactivate CYP enzymes and cause depletion of
CYP2E1 [48–50]. Figure 4 shows the activity of cytochrome10 Evidence-Based Complementary and Alternative Medicine
Table 5: Eﬀect of CCl4 and AEPD on the activities of the antioxidant enzymes in liver tissue of the normal and experimental animals.
Animal Groups Cu/Zn SOD Mn SOD CAT GST GR GPx
Vehicle 75.12±3.65(a) 65.73±3.33(a) 47.05±2.35(a) 2.25±0.21(a) 11.17±0.55(a) 91.47±4.62(a)
AEPD 69.67±3.41(a) 59.25±3.01(a) 40.57±2.02(a) 2.12±0.17(a) 10.23±0.41(a) 87.39±4.44(a)
CCl4 26.54±2.04(b) 16.38±0.95(b) 15.27±0.76(b) 0.85±0.09(b) 3.18±0.23(b) 44.25±2.25(b)
AEPD + CCl4 54.62±2.81(a),(c) 50.12±2.55(a),(c) 35.23±1.76(a),(c) 1.95±0.15(a) 9.41±0.47(a) 81.21±4.12(a)
CCl4 + AEPD 49.75±2.51(c) 45.56±2.31(c) 31.55±1.62(c) 1.75±0.12(a) 8.75±0.49(a) 76.91±3.87(a)
VitC + CCl4 60.35±3.05(a) 55.17±2.78(a) 38.39±1.92(a) 2.05±0.14(a) 10.51±0.53(a) 85.73±4.33(a)
Recovery 30.12±1.52(b) 20.43±1.04(b) 18.35±0.95(b) 0.91±0.11(b) 3.22±0.18(b) 48.31±2.45(b)
SOD—Umg−1 protein; CAT—μmolmin−1 mg−1 protein; GST—μmolmin−1 mg−1 protein; GR–nmolmin−1 mg−1 protein and GPx—nmolmin−1 mg−1
protein. Data are mean±SD, for six animals per group and were analyzed by one-way ANOVA, with Student-Newman-Keuls post hoc tests. Diﬀerences were
attributed at P<.05, and homogeneous subgroups share common superscripted letters.
123456 7
Figure 7: DNA fragmentation on agarose/ethydium bromide gel.
DNA isolated from experimental liver tissues was loaded onto 1%
(w/v) agarose gels. Lane 1: Marker (1-kb DNA ladder); lane 2: DNA
isolated from vehicle; lane 3: DNA isolated from AEPD-treated liver
samples; lane 4: DNA isolated from CCl4 intoxicated liver; lane 5:
DNA isolated from AEPD pretreated liver samples; lane 6: DNA
isolatedfromliversampleoftheAEPDpost-treatedmouseandlane
7: DNA isolated from liver sample of the mouse of recovery group.
P450 and the expression of CYP2E1 in the liver tissue of
diﬀerent experimental animals. We observed (Figure 5)a
reduced activity of cytochrome P450 (∼6 0 % )a sw e l la st h e
expressionofCYP2E1(∼72%)(Figure 6)inthelivertissueof
CCl4 intoxicated animals. Treatment with AEPD only has no
eﬀect on the activity of cytochrome P450 and the expression
of CYP2E1 however when it is applied both pre- or post-
toxin exposure then a signiﬁcant increased the activity
of cytochrome P450 and the expression of CYP2E1 was
observedcomparedtothetoxingroup.Thisﬁndingthussug-
gested the radical scavenging and antioxidant role of AEPD.
Table 6: Status of the thiol-based antioxidant in the liver tissue of
the CCl4- and AEPD-treated animals.
Animal
groups GSH GSSG Total thiols
Vehicle 29.53±1.52(a) 3.45±0.19(a) 315.31±15.76(a)
AEPD 25.74±1.29(a) 3.51±0.18(a) 305.25±15.31(a)
CCl4 8.34±0.45(b) 5.75±0.28(b) 155.89±7.85(b)
AEPD + CCl421.45±1.09(a),(c) 3.85±0.19(a) 255.34±12.74(a)
CCl4 + AEPD18.74±0.95(c) 4.01±0.21(a) 275.55±13.79(a)
VitC + CCl4 23.45±1.21(a) 3.69±0.18(a) 297.31±14.92(a)
Recovery 9.15±0.49(b) 5.55±0.27(b) 168.52±8.45(b)
GSH—nmolmg−1 protein; GSSG—nmolmg−1 protein and total thiols—
nmolmg−1 protein.Dataaremean±SD,forsixanimalspergroupandwere
analyzed by one-way ANOVA, with Student-Newman-Keuls post hoc tests.
Diﬀerences were attributed at P<.05, and homogeneous subgroups share
common superscripted letters.
3.10. DNA Damage Inhibition Eﬃciency. Oxidative stress
induced by oxygen-derived species can produce a multiplic-
ityofmodiﬁcationsinDNAincludingbaseandsugarlesions,
strand breaks, DNA-protein cross-links and base-free sites. If
left un-repaired, oxidative DNA damage can lead to detri-
mental biological consequences in organisms, including cell
death, mutations and transformation of cells to malignant
cells. In order to ﬁnd out whether AEPD protects CCl4-
induced DNA damage, DNA fragmentation was examined
byagarosegelelectrophoresis.Figure 7representstheresults.
A smear on agarose gel had been observed in CCl4-treated
group,indicatingrandomDNAfragmentation,ahallmarkof
necrosis. AEPD pretreatment found to be eﬀective to prevent
the toxin-induced smear formation suggesting that AEPD
possessestheprotectivepowerforthepreventionoflivercells
from CCl4-induced DNA damage and necrotic death.
3.11. Cell Death Pathways. To understand the nature of cell
death due to CCl4 toxicity, double labeling techniques has
been utilized using Annexin V/PI to distinguish betweenEvidence-Based Complementary and Alternative Medicine 11
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Figure 8: Representative ﬂow cytometric analysis of hepatocytes from experimental animals. Vehicle: hepatocytes from normal animals,
AEPD: hepatocytes from the animals treated with AEPD only; CCl4: hepatocytes from the CCl4 intoxicated animals; AEPD + CCl4:
hepatocytes from the animals treated with AEPD prior to CCl4 intoxication; CCl4 + AEPD: hepatocytes from the animals treated with AEPD
post-CCl4 intoxication, Recovery: hepatocytes from the animals of recovery group and NaAsO2: hepatocytes from the NaAsO2 intoxicated
(100ppm in drinking water, 10 weeks) animals (Positive control). Dual parameter dot plot of FITC-lebelled Annexin V ﬂuorescence (x-axis)
versus PI-ﬂuorescence (y-axis) has been shown in logarithmic ﬂuorescence intensity. Quadrants: lower left, live cells; lower right, apoptotic
cells; upper left, necrotic cells. Data are representative of three independent experiments.12 Evidence-Based Complementary and Alternative Medicine
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Figure 9: Hematoxylin and eosin stained liver section of experimental mice. (Cont) liver section from vehicle mice (100x); (AEPD) liver
section of the mice treated with AEPD only (100x); (CCl4) mice administered with CCl4 (100x) (arrows indicate centrilobuler necrosis
extending throughout the lobule associated with severe cellular damage); (AEPD + CCl4) liver section from the AEPD pre-treated mice
(100x); (CCl4 + AEPD) liver section from the AEPD post-treated mice (100x) and (recovery) liver section from the mice of recovery group
(100x).
apoptotic and necrotic cells. Flowcytometric data (Figure 8)
revealed that, in comparison with control untreated hep-
atocytes, hepatocytes isolated from CCl4-intoxicated mice
showed maximum PI staining (∼55%), but very little
Annexin V-FITC-binding (∼5%) indicating majority of cell
deathoccursvianecroticpathway.InAEPDpretreatedgroup
the number of necrotic cells was signiﬁcantly low indicating
the extract pre-treatment prevented the hepatocytes from
CCl4-induced necrotic cell death. Post-treatment with AEPD
also reduced the CCl4-induced cell death via necrotic
pathway.
3.12. Histological Assessment. Histological assessments of
diﬀerent liver segments of the normal and experimental
animals have been presented in Figure 9.C C l 4 exposure
induced necrosis along the central vein and disorganized the
normal radiating pattern of cell plates around it. Treatment
with AEPD prior to and after the toxin exposure showedEvidence-Based Complementary and Alternative Medicine 13
a considerable improvement in liver morphology. Results
of the histological assessment support the outcome of the
earlier studies by exhibiting CCl4-induced necrosis in the
liver tissue and its protection by AEPD.
3.13. Radical Scavenging Activity in Cell Free System
3.13.1. DPPH. To begin with the evaluation of the antiox-
idant nature of AEPD, we looked for an eﬀective radical
scavenging cell free assay. So, we determined its radical
scavenging power using the DPPH radical. The experimental
results on the radical scavenging eﬀe c to fA E P Dh a v eb e e n
shown in the Figure 10. The plot shows that with increase
in concentration of AEPD the color of the DPPH radical
vanishes rapidly at 517nm. It has been observed that AEPD
showed maximum inhibition when it was incubated at a
concentration of 20mgml−1 with DPPH solution. Hence,
it can be anticipated that the active principle(s) present in
AEPD possesses potent free radical scavenging activity.
3.13.2. Hydroxyl (OH•)a n dS u p e ro x i d e( O
•
2). In addition
to the DPPH radical scavenging activity, hydroxyl and
superoxide radicals scavenging activity of AEPD has also
been investigated in cell free system and Figure 11 represent
those results. It has been observed that at a dose of
20mgml−1,A E P Dc a ne ﬀectively scavenge OH• and O
•
2
radicals. During the preparation of the plant extract, the
extraction with phosphate buﬀer followed by lyophilization
leave some superoxide dismutase which could be responsible
for the superoxide radical scavenging activity of the extract.
4. Discussion
In our body, liver is the major organ responsible for
the metabolism of drugs and toxic chemicals and thus it
is the primary target organ for nearly all toxic chemi-
cals. Various pharmacological or chemical substances (such
as acetaminophen, galactosamine, chloroform, dimethyl-
nitrosamine, etc.) are known to cause hepatic injuries.
Excessive exposure to these chemicals may cause acute liver
injury characterized by abnormality of hepatic function, and
degeneration, necrosis or apoptosis of hepatocytes, and so
forth. In modern civilization drugs or chemicals induced
liver injury has become a serious clinical problem. CCl4-
induced liver injury in one of the well established system
forxenobiotic-inducedhepatotoxicityandiscommonlyused
model for screening of the anti-hepatotoxic and/or hepato-
protective activities of the drugs. Present study investigated
the protective role of AEPD against CCl4-induced hepatic
disorders. It has been observed that CCl4 administration
caused hepatic oxidative stress and cellular death mostly
via the necrotic pathway. Treatment with AEPD both pre-
and post-CCl4 administration prevented the toxin-induced
hepatic damage.
Reduction in the liver weight to the body weight ratio
and increased activities of the serum marker enzymes ALT,
ALP are the two important physiological indices for hepatic
injury. CCl4 administration caused reduction in the ratio of
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Figure 10: DPPH radical scavenging activity of AEPD in cell free
system. Each measurement was made six times. Data represent
the average±SD of six separate experiments. Asterisk indicates the
optimum dose of AEPD at which it shows its maximum DPPH
radical scavenging activity.
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liver weight to body weight. However, both pre- and post-
treatment with AEPD were eﬀective to keep the ratio of the
liverweighttothebodyweightalmostclosetonormal.Mem-
brane permeability is altered due to the hepatocytes injury,
leading to leakage of enzymes from these cells during toxin
and drug-induced hepatotoxicity. Hepatocellular damage, as
evident from a signiﬁcant elevation in serum activities of
ALT and ALP, used as reliable markers of hepatotoxicity. In14 Evidence-Based Complementary and Alternative Medicine
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Figure 12: Schematic diagram of the antioxidative role AEPD and its protective role against CCl4-induced hepatic pathophysiology.
our study CCl4 intoxication increased the levels of serum
marker enzymes (ALT and ALP) indicating the severity of
hepatocellular damage induced by CCl4.T r e a t m e n tw i t h
AEPD in this intoxication reduced the activities of ALT as
well as ALP and thus maintained the integrity of the cellular
membrane close to normal.
Increased production of intracellular ROS plays a major
role in CCl4-induced hepato-cellular damage. We observed
that CCl4 exposure increased the production of intracel-
lular ROS as evidenced by the increased number of green
ﬂuorescent cells. Increased level of ROS induced by CCl4
suggested a higher degree of oxidative stress and extent of
cellular damage in hepatic tissues. Treatment with AEPD
against CCl4 exposure reduced the increased production of
intracellular ROS and thus kept the liver tissue normal in
normal physiology.
Over production of ROS initiates the process of lipid
peroxidation in cell membranes and cause destruction of cell
components as well as cell death [51]. Lipid peroxidation
and PC are considered to be the two important parameters
of oxidative stress. Lipid peroxidation was measured by
estimating the concentrations of TBARS as well as LHP.
Several reports have shown that hepatic lipid peroxidation
increases with the development of acute liver injury in
rats treated once with CCl4 [52, 53]. In our study we
found that CCl4 intoxication increased the levels of TBARS,
LHP and PC in the hepatic tissue of the experimental
animals. Treatment with AEPD both pre- and post-CCl4
administration attenuated the increased levels of the lipid
peroxidation and PC.
The intracellular defense mechanism comprises of var-
ious antioxidant enzymes (SOD, CAT along with GSH
dependent enzymes, GST, GR and GPx). The antioxidant
enzyme, SOD quenches O
−
2 by converting it into O2 and
H2O2 and CAT converts H2O2 into H2Oa n dO 2. GST helps
in the radical scavenging reaction of GSH. GR catalyses the
conversion of GSH from GSSG and GPx helps to consume
of H2O2 by reaction with GSH. Therefore, in order to
eliminatethefreeradicals,thesecellularantioxidantenzymes
play an important role and equilibrium exists between these
enzymes under normal physiological conditions. CCl4 expo-
sure decreased the activities of all the antioxidant enzymes.
AEPD treatment against CCl4 administration signiﬁcantly
restored the altered activities of all antioxidant enzymes.
GSH, considered as the second line of intracellular
defense system with its sulfhydryl group (–SH) is a catalyst
in disulﬁde exchange reaction. It scavenges free radicals and
R O Sa sw e l la sd e t o x i ﬁ e sv a r i o u sx e n o b i o t i c sa n dc o n s e -
quently converted itself to its oxidized form, glutathione
disulﬁde (GSSG). Thus, reduction of GSH is associated
with a rise in GSSG concentration resulting with the
depletion in GSH/GSSG ratio. In the present study, we
observed that CCl4 intoxication decreased the levels of GSH
and simultaneously increased the level of GSSG suggesting
a clear role of oxidative stress in CCl4-induced hepatic
pathophysiology. However, both pre- and post-treatment
with AEPD normalized all the levels as compared to the
respective controls.
It has been established that CCl4-induced hepatotoxicity
depends on its reductive dehalogenation, catalyzed by the
cytochrome P450 enzymes, in the endoplasmic reticulum
of hepatic cells, leading to the generation of an unstable
complex trichloromethyl radical. The trichloromethyl radi-
calmaybindeitheratthehemegroupofcytochromeP450or
at the active site of the enzyme near the heme group, leading
to the inactivation P450 pathways [54]. Among the diﬀerent
cytochrome P450 enzymes CYP2E1 play a major role in
the bioactivation of CCl4. CYP2E1-mediated metabolism of
CCl4 generated reactive free radicals and CYP2E1 protein
m i g h tb em o r es u s c e p t i b l et oC C l 4 toxicity than other CYP
isozymes. In the present study a signiﬁcant decreased activity
of cytochrome P450 and the expression of CYP2E1 wereEvidence-Based Complementary and Alternative Medicine 15
found in the hepatic tissues of CCl4 intoxicated animals,
suggesting that CYP2E1 was degraded during the process of
CCl4-inducedhepatotoxicity.TreatmentwithAEPDhowever
prevented the degradation of cytochrome P450 and CYP2E1
as well as bioactivation of CCl4 and thus protected the liver
tissue against CCl4-induced hepatic damage.
DNA strand breaks can originate from the direct mod-
iﬁcation of DNA by chemical agents or their metabolites;
from the processes of DNA excision repair, replication and
recombination; or from the process of apoptosis [55]. Direct
breakage of the DNA strands occurs when reactive oxygen
species interact with DNA [56]. The mode of cell death
induced by CCl4 was investigated using DNA fragmentation
as well as ﬂow cytometric analyses and checked whether
AEPD treatment would reduce it or not. In our study we
found that CCl4 exposure induced random fragmentation
of genomic DNA, causing formation of a DNA smear
on agarose gel. In addition to the DNA fragmentation
study, ﬂow cytometric analysis showed that CCl4 exposure
increased the population of PI staining cells compared to the
annexin-V staining cells. Thus both the smear on agarose
gel and increased number of PI staining cell indicate the
CCl4-induced cell death via necrotic pathway. Treatment
with AEPD, however, decreased the degree of CCl4-induced
necrotic cell death and protected the liver from the adverse
eﬀect of the toxin.
Although the liver is the principal site for CCl4-induced
toxicity, but there is no speciﬁc “receptor” for the actions of
CCl4. Pathological changes following CCl4 poisoning have
been identiﬁed at the biochemical and the ultra structural
level [57, 58].
Histological studies showed that CCl4-intoxication
caused considerable necrosis in the liver tissue along the
central vein. The necrosis was mostly centrilobular and
extending through the whole liver lobule. AEPD administra-
tion both pre- and post-CCl4 intoxication reduced the toxin-
induced centrilobuler necrosis and thus protected the organ.
DPPH radical scavenging assay is a convenient tool for
the determination of free radical scavenging property of a
compound in cell free system [41]. Incubation of AEPD at
various concentrations with DPPH radical diminished the
absorbance at 517nm. This experiment reveals the ability
of AEPD to scavenge DPPH radicals. In addition, we also
investigated the hydroxyl as well as superoxide radicals
scavenging activity of AEPD in cell-free system. Results
of these studies clearly showed the free-radical scavenging
activity of AEPD. It is therefore possible that in CCl4-
induced hepato-cellular damage, AEPD acts as a free-radical
scavenger which alters toxic eﬀects of CCl4 by quenching the
excessive free radicals.
Ithasbeenreported [59]thatthefruitsofP. dulce contain
about 2.5% protein, 0.4% fat, 18% carbohydrate, 77.8%
water and 1.3% ﬁber. Besides, ∼77.8 calories can be obtained
from 100g fruits of P. dulce. It also contains some essential
minerals like Ca, P, Fe, Na and K. It is also enriched with vital
vitamins like thiamine, riboﬂavin, niacin and ascorbic acid.
Few essential amino acids like valine, lysine, phenylalanine
and tryptophan have also been found in this fruit. Alcoholic
extraction yielded saponin, sterol glucoside, ﬂavone and
lecithin. In our study we also veriﬁed the presence of
ﬂavonoids, saponins, phenolics and steroids in the plant
extract. The observed eﬀects of the plant extract could be
related to chemically deﬁned compounds. Flavonoids show
their antioxidative action through scavenging or chelating
process. Phenolic content is also very important plant
constituent because of their scavenging ability due to their
hydroxyl groups. Thus the observed antioxidant eﬀectscould
be related to the presence of ﬂavonoid and phenolic content
of the extract.
Figure 12showsthepossible mechanistic pathwaysabout
the beneﬁcial role of AEPD against CCl4-induced hepatic
pathophysiology. Here it has been observed that free radical
scavenging activity of AEPD prevented the toxin induced
over production of ROS. Besides, inhibition of the degra-
dation of cytochrome P450 isoenzymes also reduced the
bioactivation of CCl4 and its metabolite. Thus AEPD plays
a protective role against CCl4-induced hepatic impairment
via reducing oxidative stress and degradation of cytochrome
P450s.
Inconclusion,wewouldliketomentionthatAEPDcould
be a useful agent against CCl4-induced hepatic pathophysi-
ology (Figure 12). However, further studies are necessary to
entirely characterize the active ingredient(s) of this fruit as
well as the exact mechanism(s) of its protective action.
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